Literature DB >> 20636880

The orally combined neuroprotective effects of sodium ferulate and borneol against transient global ischaemia in C57 BL/6J mice.

Xiao-Hong Chen1, Zhu-Zhen Lin, An-Min Liu, Jian-Tao Ye, Yan Luo, Yu-Yan Luo, Xue-Xuan Mao, Pei-Qing Liu, Rong-Biao Pi.   

Abstract

OBJECTIVES: This study aimed to investigate the possible modification of the neuroprotective effect of sodium ferulate, when orally co-administered with borneol, in transient global cerebral ischaemia-induced functional, histological and cellular alterations in mice.
METHODS: The bilateral common carotid artery occlusion was conducted in C57 BL/6J mice for 25 min. The mice were then subjected to a water maze test over an extended recovery period, followed by an assessment of neuronal loss in the CA1 region of the hippocampus (haematoxylin and eosin staining). The blood-brain barrier permeability (Evans blue tracing), brain oedema and oxidative stress were assayed and histological sections were also immunostained for gliofibrillar acid protein (GFAP) expression. KEY
FINDINGS: The ischaemia reperfused mice were associated with long-lasting spatial learning deficits in the absence of other behavioural impairments and with neurodegeneration in the hippocampal CA1 region. However, the histological injuries were significantly attenuated by oral co-administration of sodium ferulate and borneol. Furthermore, combined treatment with sodium ferulate and borneol resulted in a significant reduction in brain oedema, GFAP-positive cells, malonaldialdehyde levels and blood-brain barrier permeability, but an increase in superoxide dismutase activity.
CONCLUSIONS: Borneol may have benefits for the neuroprotective effect of sodium ferulate against injury induced in the brain by ischaemia/reperfusion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20636880     DOI: 10.1211/jpp.62.07.0013

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  15 in total

1.  Time-course investigation of blood-brain barrier permeability and tight junction protein changes in a rat model of permanent focal ischemia.

Authors:  Peng Liu; Rui Zhang; Danyang Liu; Jinling Wang; Chunling Yuan; Xuemei Zhao; Yinjie Li; Xuefei Ji; Tianyan Chi; Libo Zou
Journal:  J Physiol Sci       Date:  2017-01-11       Impact factor: 2.781

2.  Schwann cell proliferation and differentiation that is induced by ferulic acid through MEK1/ERK1/2 signalling promotes peripheral nerve remyelination following crush injury in rats.

Authors:  Xiaoyan Zhu; Kun Li; Xin Guo; Jian Wang; Yang Xiang
Journal:  Exp Ther Med       Date:  2016-07-14       Impact factor: 2.447

3.  Hesperidin attenuates oxidative and neuronal damage caused by global cerebral ischemia/reperfusion in a C57BL/J6 mouse model.

Authors:  M Namik Oztanir; Osman Ciftci; Aslı Cetin; M Arif Aladag
Journal:  Neurol Sci       Date:  2014-03-28       Impact factor: 3.307

4.  Tetramethylpyrazine phosphate and borneol combination therapy synergistically attenuated ischemia-reperfusion injury of the hypothalamus and striatum via regulation of apoptosis and autophagy in a rat model.

Authors:  Bin Yu; Ming Ruan; Tao Liang; Shi-Wen Huang; Sheng-Jin Liu; Hai-Bo Cheng; Xiang-Chun Shen
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

5.  The beneficial effects of 18β-glycyrrhetinic acid following oxidative and neuronal damage in brain tissue caused by global cerebral ischemia/reperfusion in a C57BL/J6 mouse model.

Authors:  M Namik Oztanir; Osman Ciftci; Aslı Cetin; M Akif Durak; Nese Basak; Yener Akyuva
Journal:  Neurol Sci       Date:  2014-02-20       Impact factor: 3.307

6.  Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood-brain barrier permeability.

Authors:  Qun-Lin Zhang; Bingmei M Fu; Zhang-Jin Zhang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

7.  Tacrine-6-ferulic acid, a novel multifunctional dimer, inhibits amyloid-β-mediated Alzheimer's disease-associated pathogenesis in vitro and in vivo.

Authors:  Rongbiao Pi; Xuexuan Mao; Xiaojuan Chao; Zhiyi Cheng; Mengfei Liu; Xiaolu Duan; Mingzhong Ye; Xiaohong Chen; Zhengrong Mei; Peiqing Liu; Wenming Li; Yifan Han
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

8.  Borneol Attenuates Ultrasound-Targeted Microbubble Destruction-Induced Blood-Brain Barrier Opening in Focal Cerebral Ischemia.

Authors:  Xiao-Guang Zhang; Ye Song; Chang Shan; Xi-Fan Wu; Yan-Hua Tong; Xin-Chun Jin; Wen-Lan Liu; Guo-Qing Zheng; Jie Liu
Journal:  Front Neurol       Date:  2017-12-22       Impact factor: 4.003

9.  A system-level investigation into the mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for cardiovascular disease treatment.

Authors:  Xiuxiu Li; Xue Xu; Jinan Wang; Hua Yu; Xia Wang; Hongjun Yang; Haiyu Xu; Shihuan Tang; Yan Li; Ling Yang; Luqi Huang; Yonghua Wang; Shengli Yang
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

10.  Suxiao jiuxin pill induces potent relaxation and inhibition on contraction in human artery and the mechanism.

Authors:  Xiao-Yan Bai; Ping Zhang; Qin Yang; Xiao-Cheng Liu; Jun Wang; Yong-Ling Tong; Song-Jin Xiong; Li-Hua Liu; Lei Wang; Guo-Wei He
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-07       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.